Recurrent epimutation of SDHC in gastrointestinal stromal tumors
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Methylation of the SDH gene explains the loss of SDH gene expression in SDH wild-type gastrointestinal stromal tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“Samples were annotated into SDHx-mutant versus SDHx-WT groups as described above (SDHxmutation analysis), and the between-group significance of each 450K methylation CpG target variable or U133P2 probe set variable [q value, a false discovery rate–corrected P value (30)] was computed in QOE, which uses a t test for tw…”
MethodMutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612 · cited 1×
“S2), consistent with the Knudson two-hit model of tumor suppressor gene inactivation (24).”
ResultFigueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu, Y., et al. (2012) · Genes & Development · doi:10.1101/gad.191056.112 · Cited by 1,188
Pollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi227 · Cited by 865
SDH mutations establish a hypermethylator phenotype in paraganglioma
Letouzé, E., Martinelli, C., Loriot, C., Burnichon, N., Abermil, N., Ottolenghi, C., Janin, M., Menara, M., Nguyen, A. T., Benit, P., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.018 · Cited by 776
Pansuriya, T. C., van Eijk, R., d'Adamo, P., van Ruler, M. A. J. H., Kuijjer, M. L., Oosting, J., Cleton-Jansen, A.-M., van Oosterwijk, J. G., Verbeke, S. L. J., Meijer, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.1004 · Cited by 559
Carney, J. A. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.6.543 · Cited by 435
Miettinen, M., Wang, Z.-F., Sarlomo-Rikala, M., Osuch, C., Rutkowski, P., & Lasota, J. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182260752 · Cited by 363 · cited 1×
“Cases were selected on the basis of SDHB-negative immunophenotype by immunohistochemistry, a sensitive and specific marker for SDH deficiency (22).”
BackgroundSelf-citationMacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359
Killian, J. K., Kim, S. Y., Miettinen, M., Smith, C., Merino, M., Tsokos, M., Quezado, M., Smith, W. I., Jahromi, M. S., Xekouki, P., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0092 · Cited by 356
Self-citationPromoter-Bound Trinucleotide Repeat mRNA Drives Epigenetic Silencing in Fragile X Syndrome
Colak, D., Zaninovic, N., Cohen, M. S., Rosenwaks, Z., Yang, W.-Y., Gerhardt, J., Disney, M. D., & Jaffrey, S. R. (2014) · Science · doi:10.1126/science.1245831 · Cited by 294
Prakash, S., Sarran, L., Socci, N., DeMatteo, R. P., Eisenstat, J., Greco, A. M., Maki, R. G., Wexler, L. H., LaQuaglia, M. P., Besmer, P., et al. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000157790.81329.47 · Cited by 271
Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors
Agaram, N. P., Laquaglia, M. P., Ustun, B., Guo, T., Wong, G. C., Socci, N. D., Maki, R. G., DeMatteo, R. P., Besmer, P., & Antonescu, C. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1984 · Cited by 250
Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia
Gill, A. J. (2012) · Pathology · doi:10.1097/pat.0b013e3283539932 · Cited by 215
Miettinen, M., Killian, J. K., Wang, Z.-F., Lasota, J., Lau, C., Jones, L., Walker, R., Pineda, M., Zhu, Y. J., Kim, S. Y., et al. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182671178 · Cited by 195
Self-citationAberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad
Haller, F., Moskalev, E. A., Faucz, F. R., Barthelmeß, S., Wiemann, S., Bieg, M., Assie, G., Bertherat, J., Schaefer, I.-M., Otto, C., et al. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-14-0254 · Cited by 189 · cited 2×
“Stand-alone SDHC epimutation in SDHx-WT GIST in our study contrasts with a recently proposed molecular triad of simultaneous chromosome 1q deletion and SDHB and SDHC promoter methylation that were based on a high–cycle number (60-cycle) bisulfite polymerase chain reaction (PCR) assay applied to a series of three Carne…”
BackgroundMethodGenomic insights into cancer-associated aberrant CpG island hypermethylation
Sproul, D., & Meehan, R. R. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/els063 · Cited by 162
Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells
Cervera, A. M., Bayley, J.-P., Devilee, P., & McCreath, K. J. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-89 · Cited by 156
Matyakhina, L., Bei, T. A., McWhinney, S. R., Pasini, B., Cameron, S., Gunawan, B., Stergiopoulos, S. G., Boikos, S. A., Muchow, M., Dutra, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0797 · Cited by 152
Self-citationThe role of epigenetics in Lynch syndrome
Hitchins, M. P. (2013) · Familial Cancer · doi:10.1007/s10689-013-9613-3 · Cited by 101 · cited 3×
“Promoter methylation of pathogenicity genes in fragile X and Lynch syndromes often stems from genomic anomalies proximal to FMR1 and MSH2, respectively (20, 21).”
BackgroundInfluentialAn Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma
Baysal, B. E., Willett-Brozick, J. E., Filho, P. A. A., Lawrence, E. C., Myers, E. N., & Ferrell, R. E. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.019224 · Cited by 78 · cited 1×
“4-kbp germline intragenic deletion in SDHC, identical to that previously reported in a paraganglioma (27) (known as the “Pittsburgh mutation”), with tumor LOH in the remaining allele; however, outside of relatively rare instances of germline SDHC intragenic deletions in patients with paraganglioma and/or GIST that the…”
BackgroundLasota, J. P., Wang, Z., Kim, S. Y., Helman, L. J., & Miettinen, M. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182613c86 · Cited by 72
Self-citationBelinsky, M. G., Rink, L. A., Flieder, D. B., Jahromi, M. S., Schiffman, J. D., Godwin, A. K., & von Mehren, M. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22023 · Cited by 72
Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors
Belinsky, M. G., Rink, L., & von Mehren, M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00117 · Cited by 66 · cited 4×
“The multimeric respiratory complex II/succinate dehydrogenase (SDH)/ succinate ubiquinone oxidoreductase (SQR) is an integral component of both the mitochondrial Krebs cycle and respiratory chain [reviewed in (1)], and its four protein subunits (SDHA, SDHB, SDHC, and SDHD) are encoded by nuclear genes.”
BackgroundInfluentialThe role of mutation of metabolism-related genes in genomic hypermethylation
Waterfall, J. J., Killian, J. K., & Meltzer, P. S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.003 · Cited by 24
Self-citationKillian, J. K., Bilke, S., Davis, S. R., Walker, R. L., Jaeger, E. B., Killian, M. S., Waterfall, J. J., Bibikova, M. V., Fan, J., Smith, W. I., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.022 · Cited by 18
Self-citation
Cited by
Epigenetic plasticity and the hallmarks of cancer
Flavahan, W. A., Gaskell, E., & Bernstein, B. E. (2017) · Science · doi:10.1126/science.aal2380 · Cited by 1,340
“Reduced SDH expression increases succinate levels and inhibits DNA demethylation, potentially reinforcing the initial methylation event and causing global hypermethylation (87).”
BackgroundBoikos, S. A., Pappo, A. S., Killian, J. K., LaQuaglia, M. P., Weldon, C. B., George, S., Trent, J. C., von Mehren, M., Wright, J. A., Schiffman, J. D., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0256 · Cited by 416
Self-citationNew Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Crona, J., Taïeb, D., & Pacak, K. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00062 · Cited by 324
Gastrointestinal Stromal Tumors
von Mehren, M., & Joensuu, H. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9705 · Cited by 306
Mitochondrial complex ii: At the crossroads
Bezawork-Geleta, A., Rohlena, J., Dong, L., Pacak, K., & Neuzil, J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.01.003 · Cited by 295
“Emerging data thus indicate a link between mutations and the epigenomic regulation of genes encoding SDHC subunits and neoplasias [78,80].”
Metadata
- Authors
- Killian, J. K., Miettinen, M., Walker, R. L., Wang, Y., Zhu, Y. J., Waterfall, J. J., Noyes, N., Retnakumar, P., Yang, Z., Smith, W. I., Killian, M. S., Lau, C. C., Pineda, M., Walling, J., Stevenson, H., Smith, C., Wang, Z., Lasota, J., Kim, S. Y., Boikos, S. A., Helman, L. J., & Meltzer, P. S.
- Venue
- Science Translational Medicine
- Published
- 2014-12-24
- Volume
- 6
- Issue
- 268
- Pages
- 268ra177-268ra177
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2117727059
- Cited by
- 193
- References
- 29
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.